These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 19542087

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV, Renwick WE, Hogan C, Haeusler M, Tuckfield A, Tatoulis J.
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [Abstract] [Full Text] [Related]

  • 3. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 4. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [Abstract] [Full Text] [Related]

  • 11. Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.
    Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA, Ikonomidis JS.
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1469-77.e2. PubMed ID: 21457998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
    Guzzetta NA, Russell IA, Williams GD.
    Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.